10-12-2025 17:28 via drugs.com

Pegcetacoplan Beneficial for C3 Glomerulopathy, Immune-Complex MPGN

WEDNESDAY, Dec. 10, 2025-- Among patients with C3 glomerulopathy or primary immune-complex membranoproliferative glomerulonephritis (MPGN), pegcetacoplan, a C3 and C3b inhibitor, yields a significantly greater reduction in proteinuria than...
Read more »

Pharmaceutical Industry news



SABCS: Breast MRI Does Not Increase Local Regional Control in Some Early-Stage Breast Cancers
Planned Early-Term Birth Cuts Preeclampsia Incidence in High-Risk Women
Air Pollution Tied to Diminished Benefits of Regular Exercise
SABCS: Omission of SLNB Safe in Clinically T1-2 Node-Negative Breast Cancer
Data-Driven Surgical Supply Lists Cut Waste, Cost
Prehabilitation Cuts Postsurgical Disability in Older Adults With Frailty
Plasma p-tau217 Can Reliably Detect Preclinical Alzheimer Disease
One in 10 Teens, Young Adults With Cancer Later Develop Metastatic Recurrence
Mental Health Conditions May Increase Risk for Liver Cancer in Veterans With Cirrhosis
Guidelines Updated on Use of Parenteral Meds for Migraine in Emergency Department
Excessive Heat Harms Early Childhood Development
2000 to 2022 Saw Rise in Hospital Resource Use for Children With Complex Chronic Conditions
Nitrous Oxide May Help With Depressive Symptoms
Low Capability Pediatric Hospitals More Than Doubled From 2003 to 2022
Desktop versie